New humira copycat under the microscope: will it match up?
NCT ID NCT07181694
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a new biosimilar drug called BCD-057, which is a copy of the arthritis medication Humira. It will involve 444 healthy men aged 18-45 who receive a single injection of either BCD-057 or Humira. The goal is to see if the body processes the two drugs similarly and to check for any side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Adalimumab (a biosimilar version of the drug Humira)
What this could lead to
If successful, this could show that BCD-057 works similarly to Humira, potentially offering a more affordable treatment option for inflammatory conditions.
What could go wrong
This is an early Phase 1 study in healthy volunteers, not patients. It only tests a single dose, so it cannot predict long-term safety or effectiveness in treating disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
I.M. Sechenov First Moscow State Medical University
RECRUITINGMoscow, 119435, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LLC "Research Center Eco-Safety"
RECRUITINGSaint Petersburg, 196143, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LLC "X7 Clinical Research"
RECRUITINGSaint Petersburg, 194156, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
LLC "X7 Clinical Research"
RECRUITINGSaint Petersburg, 199178, Russia
Contact Phone: •••-•••-•••• Email: •••••@•••••